Inventor · disambiguated record
Edgar Schmitt
Also filed as: SCHMITT EDGAR
3 granted patents·3 pending applications·1 citations·filing 2004–2020
53Inventor score
Top patents by PatentIndex Score
6 records- 0164US8557533B2Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4SCHNEIDER FRANZ-JOSEF·Filed 2008·Granted Oct 15, 2013·1 cites·35 claims
- 0263US2020316167A1Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4UNIV DER JOHANNES GUTENBERG UNIV MAINZ·Filed 2020·Application pending·0 cites
- 0352US10729742B2Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4TCF GMBH·Filed 2016·Granted Aug 4, 2020·0 cites·2 claims
- 0451US2008118515A1Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of DiseasesPROTAGEN AG·Filed 2004·Application pending·0 cites
- 0548US2014093509A1Screening Method for the Identification of Agents Capable of Activating CD4+CD25+ Regulatory T-Cells Through Interactions with the HIV-1 GP120 Binding Site on CD4TCF GMBH·Filed 2013·Application pending·0 cites
- 0645US12084511B2Peptide-based compounds for use in the prevention, treatment and/or detection of cancerUNIV DER JOHANNES GUTENBERG UNIV MAINZ·Filed 2019·Granted Sep 10, 2024·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Edgar Schmitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →